Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors :: Hoppe RT
Advani RH
Ai WZ
Ambinder RF
Aoun P
Bello CM
Benitez CM
Bernat K
Bierman PJ
Blum KA
Chen R
Dabaja B
Forero A
Gordon LI
Hernandez-Ilizaliturri FJ
Hochberg EP
Huang J
Johnston PB
Kaminski MS
Kenkre VP
Khan N
Maloney DG
Mauch PM
Metzger M
Moore JO
Morgan D
Moskowitz CH
Mulroney C
Poppe M
Rabinovitch R
Seropian S
Smith M
Winter JN
Yahalom J
Burns J
Ogba N
Sundar H
Source :: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2017 May; Vol. 15 (5), pp. 608-638.
Publication Year :: 2017
Abstract: This portion of the NCCN Guidelines for Hodgkin lymphoma (HL) focuses on the management of classical HL. Current management of classical HL involves initial treatment with chemotherapy or combined modality therapy followed by restaging with PET/CT to assess treatment response using the Deauville criteria (5-point scale). The introduction of less toxic and more effective regimens has significantly advanced HL cure rates. However, long-term follow-up after completion of treatment is essential to determine potential long-term effects.<br /> (Copyright © 2017 by the National Comprehensive Cancer Network.)